AIM:ARBB
AIM:ARBBBanks

Top UK Dividend Stocks To Consider In November 2025

As the FTSE 100 index reflects the impact of weak trade data from China, investors in the UK are navigating a market influenced by global economic challenges and fluctuating commodity prices. In such an environment, dividend stocks can offer a measure of stability and income potential, making them an attractive consideration for those looking to weather uncertain market conditions.
NYSE:SILA
NYSE:SILAHealth Care REITs

Sila Realty Trust (SILA): Earnings Growth of 54.5% Reinforces Bullish Margin Expansion Narratives

Sila Realty Trust (SILA) delivered another set of high quality earnings, with profitability expanding at an impressive 44.7% annually over the past five years and most recently recording earnings growth of 54.5%. Net profit margins have climbed to 20.9%, up from last year’s 13.6%. Revenue is forecast to grow at 9.6% per year, with earnings expected to rise 12.8% annually, even though both rates fall short of the broader US market. Trading below analyst estimates of fair value and with margins...
TSX:CURA
TSX:CURAPharmaceuticals

Is Now the Right Time to Revisit Curaleaf After Federal Cannabis Reform Talks in 2025?

If you've been wondering whether Curaleaf Holdings is attractively valued right now, you're not alone. We're about to break down all the angles worth considering. The stock has soared 74.3% year-to-date and is up 31.9% over the past year. However, recent weeks have seen momentum cool off just a bit after a strong run. This shift in sentiment follows news of broader legislative discussions on U.S. cannabis reform. Renewed debates have sparked investor optimism about the potential for federal...
NasdaqGM:NAMS
NasdaqGM:NAMSBiotechs

NewAmsterdam Pharma (NAMS): Losses Worsen by 52% Annually as Revenue Forecasts Outpace Market

NewAmsterdam Pharma (NasdaqGM:NAMS) remains unprofitable, with net losses worsening at an average annual rate of 52% over the past five years. While the company is forecast to stay in the red for at least the next three years, revenue is expected to surge by 59.1% per year, outpacing the broader US market’s 10.5% annual growth. Despite its stock trading below the estimated fair value of $69.50, investors should note share dilution over the past year and ongoing profitability challenges even...
TSXV:DE
TSXV:DEIndustrials

Decisive Dividend (TSXV:DE): One-Off CA$3.3M Loss Renews Dividend Stability Concerns

Decisive Dividend (TSXV:DE) posted revenue forecast growth of 6.38% per year, outpacing the Canadian market’s expected 5.1% rate. EPS surged with a 34% increase in earnings over the past year, and the company’s five-year annual earnings growth stands at 29.9%. Net profit margins moved up to 4% from 3.3%, despite a one-off loss of CA$3.3 million weighing on the latest results. For investors, the consistent profit growth and improving margins set up a nuanced picture as the market now weighs...
NasdaqGS:PCH
NasdaqGS:PCHSpecialized REITs

Does PotlatchDeltic’s Share Slide Signal Opportunity After Strong Real Estate News?

Wondering whether PotlatchDeltic offers good value right now? You are not alone, as investors often question how to weigh timberland assets and real estate against the current share price. After a solid start to the year, PotlatchDeltic’s share price is up just 0.9% year-to-date. However, it dipped by -2.9% over the past week and has slid -7.6% in the last month, highlighting some recent volatility. Recent news around continued strength in the real estate sector and the company’s strategic...
NYSE:FIS
NYSE:FISDiversified Financial

FIS Profit Margin Drops to 1.5% on $497 Million Loss, Challenging Bullish Narratives

Fidelity National Information Services (FIS) posted net profit margins of 1.5%, down from 5.5% a year ago, as results for the twelve months ending September 30, 2025, were weighed by a sizeable one-off loss of $497.0 million. While revenue is forecast to grow at 4.2% annually, trailing the broader US market’s expected 10.5% rate, FIS’s earnings are projected to surge at 31.5% per year. This is far ahead of the anticipated 16% annual growth for the US market, even after recent margin pressures...
OM:SALT B
OM:SALT BMachinery

SaltX Technology Holding (OM:SALT B): Losses Worsen, Premium Valuation Challenges Market Optimism

SaltX Technology Holding (OM:SALT B) remains unprofitable, with net profit margins showing no improvement over the last year and losses deepening by 10.5% annually over the past five years. The Price-to-Sales Ratio stands at 18.7x, which is a substantial premium to both the Swedish machinery industry average of 1.8x and the peer group’s 2.8x. With shares trading at such a high valuation despite mounting losses and no visible improvement in profitability, the current results underline the...
NasdaqGS:INMD
NasdaqGS:INMDMedical Equipment

InMode (INMD) Profit Margin Surges to 44.5%, Reinforcing Bullish Narratives on Value and Growth

InMode (INMD) delivered net profit margins of 44.5%, up from last year’s 35.8%, while earnings for the year climbed 19.8%, outperforming its five-year annual average. The current share price sits at $14.53, significantly below the estimated fair value of $29.82, and the company’s Price-To-Earnings ratio of 5.1x stands well under industry and peer averages. With robust profitability, steady profit growth, and positive valuation signals, investors may find the current setup supportive, even...
NYSE:BDX
NYSE:BDXMedical Equipment

Does the Recent 22% Drop Signal Opportunity in Becton Dickinson’s Share Price for 2025?

Wondering whether Becton Dickinson is offering a bargain or trading above its worth? You are not alone, and it pays to dig deeper into what drives its share price. The stock has seen turbulence lately, sliding 2.8% over the past week and losing 8.1% in the last month, with the year-to-date performance down a noteworthy 22.1%. Recently, shares reacted to closely watched sector updates, including ongoing debates over healthcare supply chain pressures and innovation in medical devices...
XTRA:EVK
XTRA:EVKChemicals

Evonik (XTRA:EVK) Margins Fall to 0.7% on €242M Loss, Testing Turnaround Narrative

Evonik Industries (XTRA:EVK) posted a mixed set of results for investors, as EPS was pressured by a one-off €242 million loss over the past 12 months, dragging net profit margins down to 0.7% from 1.5% last year. Earnings have declined at an average annual rate of 32.4% over the past five years, but projections are turning heads. The company now expects earnings to grow 35.7% annually, which is significantly higher than the German market's 16.9% yearly growth forecast. While EVK's revenue...
NasdaqGS:HAS
NasdaqGS:HASLeisure

Hasbro’s Valuation After New Partnership and 36% Share Price Run in 2025

Are you wondering whether Hasbro’s recent run-up means the stock is a hidden gem, or if there’s more to the story beneath the surface? After climbing 36.2% year-to-date, Hasbro’s share price has outpaced many of its peers, with a notable 26.2% gain over the past 12 months, even while seeing a modest dip of 1.4% this week. These price moves have coincided with the company making headlines for a new partnership deal that could broaden its entertainment reach, along with a sale of non-core...
NYSE:TOST
NYSE:TOSTDiversified Financial

Toast (TOST) Profitability Surges, Challenging Cautious Valuation Narratives with 40% Annual Earnings Growth

Toast (TOST) marked a major milestone over the last year as it transitioned to profitability, with earnings climbing at a remarkable 40.2% annual rate over the past five years. Net profit margins also improved, and forecasts now call for earnings to grow 26.4% per year, well ahead of the broader US market’s 15.8% pace. With revenue expected to increase 14.8% annually, Toast looks set for significant near-term profit growth. However, its lofty 101.6x price-to-earnings ratio could raise...
NasdaqGS:BSY
NasdaqGS:BSYSoftware

Bentley Systems (BSY) Margin Decline Sparks Debate Over Valuation Premiums and Growth Narratives

Bentley Systems (BSY) posted a net profit margin of 17.9%, down from last year’s 29.2%, with the company’s earnings showing negative growth relative to the prior year after averaging 24.2% annual growth over the past five years. The share price currently stands at $48.48, which is above some fair value estimates. Ongoing forecasts suggest earnings will grow 14.9% per year and revenue will grow 8.6% per year, both trailing the broader US market. Margins compressed during this period, but...
NasdaqGM:NUAI
NasdaqGM:NUAIOil and Gas

Assessing New Era Energy & Digital (NUAI) Valuation Following Sustainability Initiatives and Texas Data Center Progress

On November 4, New Era Energy & Digital (NUAI) shared updates in its Q4 2025 investor presentation and unveiled strategic moves toward sustainability. The company detailed progress on its Texas Critical Data Centers project and emphasized efforts to improve power reliability. See our latest analysis for New Era Energy & Digital. Momentum has surged for New Era Energy & Digital, with a 1-month share price return of nearly 217% and a massive 1,366% rise over the last 90 days, following its...
NYSE:DBD
NYSE:DBDTech

Diebold Nixdorf (DBD): Deep Discount to Fair Value Reinforces Optimistic Turnaround Narrative

Diebold Nixdorf (DBD) remains unprofitable, but losses have narrowed significantly over the last five years at an annual rate of 41%. The company is expected to grow earnings at 36.43% per year, with a return to profit forecast within three years. This pace is well above the broader market. Revenue growth is projected at a slower 3% per year, which may not excite those hunting for top-line acceleration. However, current valuation metrics like a 0.6x price-to-sales ratio and trading well below...
NasdaqGS:MYGN
NasdaqGS:MYGNBiotechs

Myriad Genetics (MYGN): Losses Compound at 21.1% Annually, Undercutting Value Narrative

Myriad Genetics (MYGN) remains in the red, with losses having climbed at a 21.1% annualized rate over the past five years, and the company is expected to stay unprofitable for at least the next three years. While revenue is forecast to grow 4.5% per year, which is less than half the 10.5% broader US market expectation, shares currently trade at $6.58, below an estimated fair value of $9.83. Despite a low price-to-sales ratio of 0.7x, ongoing net losses and a slower revenue trajectory continue...
NYSE:IRM
NYSE:IRMSpecialized REITs

Iron Mountain (IRM) Margin Hit Reinforces Debate Over Long-Term Value Versus Profit Compression

Iron Mountain (IRM) posted a net profit margin of just 0.6% this period, slipping from 3.9% a year ago, as EPS fell sharply. Over the last twelve months, results took a hit from a one-off loss of $221.6 million, and earnings have declined at a painful rate of 21.3% per year over the past five years. With the stock trading at $100.47, investors are left weighing slower revenue growth forecasts of 8.6% per year against an expected 43.3% annual recovery in earnings over the next three years...
NasdaqCM:NEOV
NasdaqCM:NEOVElectrical

What NeoVolta (NEOV)'s Record Q1 2026 Revenue Guidance Means For Shareholders

NeoVolta Inc. recently provided revenue guidance for the first quarter of fiscal 2026, anticipating revenue of over US$6.5 million, a very large year-over-year increase and the company's fourth consecutive record-setting quarter, following US$8.4 million in total revenue for fiscal 2025. This projection represents NeoVolta’s highest quarterly revenue to date and highlights an accelerating growth trajectory in the company’s market positioning. We’ll explore how NeoVolta’s continued quarterly...
LSE:BOWL
LSE:BOWLHospitality

European Small Caps With Insider Buying Highlighting Undervalued Opportunities

In recent weeks, European markets have experienced mixed performances, with the pan-European STOXX Europe 600 Index slightly declining after reaching new highs, as expectations for further interest rate cuts from the European Central Bank diminished. Amid these fluctuating market conditions and a stable economic backdrop with inflation near target levels, investors are increasingly focusing on small-cap stocks that may offer unique opportunities. Identifying promising small-cap companies...
OM:AXFO
OM:AXFOConsumer Retailing

European Market: 3 Stocks That Could Be Trading Below Fair Value

In recent weeks, the European market has experienced mixed performances across major stock indexes, with the pan-European STOXX Europe 600 Index declining slightly as expectations for further interest rate cuts from the European Central Bank diminished. Amid this backdrop of cautious monetary policy and steady inflation rates near target levels, investors are increasingly on the lookout for stocks that may be trading below their fair value, offering potential opportunities in a market...